WP-1303 (H-1129), a novel antiglaucoma agent, lowers intraocular pressure by increasing conventional outflow in rabbits and monkeys.
Yuji Takahashi(Iwate Medical University), Akira Naito(Wakamoto Pharmaceutical (Japan)), Shunsuke Imai(RIKEN Center for Integrative Medical Sciences), Takashi Inoue(Hokkaido University), Reijiro Arakawa(Wakamoto Pharmaceutical (Japan)), Tomohiro Otsuka(Wakamoto Pharmaceutical (Japan))
Investigative Ophthalmology & Visual Science
July 13, 2018
Cited by 0
Related Papers
Summary Report on the ISOBM TD-4 Workshop: Analysis of 56 Monoclonal Antibodies against the MUC1 Mucin
|Tumor Biology|1998|216
Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity
|European Journal of Pharmacology|2010|156
Reg1ulatory Role and Molecular Interactions of a Cell-Surface Heparan Sulfate Proteoglycan (<i>N</i>-syndecan) in Hippocampal Long-Term Potentiation
|Journal of Neuroscience|1999|119
Structural basis underlying the dual gate properties of KcsA
|Proceedings of the National Academy of Sciences|2010|115
Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage<i>in vitro</i>and<i>in vivo</i>
|Molecular Nutrition & Food Research|2009|98